Inhibikase Therapeutics, Inc. (IKT) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - IKT

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Equity

1Y Growth82.26%

5Y CAGR77.60%

10Y CAGRN/A

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	111.0%	-71.0%	-28.0%	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	-96.0%	-58.0%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	343.9%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - IKT

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Inhibikase Therapeutics, Inc.

Compare with peers

Explore

Growth Analysis - IKT

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Inhibikase Therapeutics, Inc.

Compare with peers

Explore